Osteopenia Completed Phase 3 Trials for Teriparatide (DB06285)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00065637Once Weekly Parathyroid Hormone for OsteoporosisTreatment